14 Jul 2011 Seattle Genetics Announces Unanimous Recommendations from FDA Advisory Committee in Favor of Accelerated Approval of ADCETRIS for Post-Transplant Relapsed Hodgkin Lymphoma and Relapsed or Refractory Systemic ALCL
14 Jul 2011 YERVOY (ipilimumab) Approved for the Treatment of Previously-Treated Advanced Melanoma in the EU
11 Jul 2011 Advaxis Completes Enrollment of Low Dose Cohort in CIN Study
11 Jul 2011 GlaxoSmithKline (GSK) Receives FDA Approval for BOOSTRIX to Help Prevent Whooping Cough in Adults 65 Years and Older
07 Jul 2011 Inovio Expands DNA Vaccine Intellectual Property License With the University of Pennsylvania
05 Jul 2011 Inovio Pharmaceuticals Synthetic DNA Vaccine Protects Against HIV in Non-Human Primates
04 Jul 2011 Sorrento Therapeutics' Innovative Approach to Developing Vaccines and Therapeutics for MRSA Receives Continued Support From the National Institute of Allergy and Infectious Diseases
30 Jun 2011 Scancell Develops New Vaccine for the Treatment of Lung Cancer
30 Jun 2011 Inovio Pharmaceuticals' DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study
30 Jun 2011 Medicago reports positive Phase II final results for its avian flu pandemic vaccine
29 Jun 2011 Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
28 Jun 2011 VaxyGen Vaccines Ltd. Announces Exclusive Strategic Vaccine Collaboration with The Serum Institute of India (SII)
28 Jun 2011 Vical Provides Allovectin(R) and Herpes Simplex Vaccine Updates at BIO International Convention
28 Jun 2011 Diamyd Medical: Diamyd Presents Detailed Results of European Phase III Study
28 Jun 2011 Sinovac Commences Phase II Clinical Trial for EV71 Vaccine
27 Jun 2011 PharmAthene Achieves Anthrax Vaccine Program Milestone and Successfully Completes Technology Transfer
24 Jun 2011 Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax
23 Jun 2011 GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine
23 Jun 2011 Diamyd Medical: Diamyd Initiates Closure of US Phase III study
21 Jun 2011 Mayo Clinic Researchers Use Human Vaccine to Cure Prostate Cancer in Mice
21 Jun 2011 Hemispherx Biopharma's Ampligen(R) Tested in Combination With Experimental Vaccine From Leading Cancer Research Institute
21 Jun 2011 NanoBio Announces First Patients Vaccinated in Phase 1b Intranasal Influenza Vaccine Study
20 Jun 2011 Hib Vaccine TAK-816 Enters into the Phase III Clinical Trial in Japan
20 Jun 2011 FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine
16 Jun 2011 Novartis application for expanded Menveo(R) indication from 2 months of age accepted for review by FDA

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up